At close: December 20 at 4:00:01 PM EST
After hours: 7:53:21 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.43 | -0.42 | -2.05 | -1.65 |
| Low Estimate | -0.43 | -0.42 | -2.05 | -1.65 |
| High Estimate | -0.43 | -0.42 | -2.05 | -1.65 |
| Year Ago EPS | -- | -1.1 | -- | -2.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -2.32 | -0.41 | -0.58 | -0.4 |
| EPS Actual | -2.08 | -1.1 | -0.39 | -0.47 |
| Difference | 0.23 | -0.69 | 0.19 | -0.07 |
| Surprise % | 10.15% | -169.12% | 32.67% | -17.90% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.43 | -0.42 | -2.05 | -1.65 |
| 7 Days Ago | -0.39 | -0.38 | -1.9 | -1.65 |
| 30 Days Ago | -0.39 | -0.38 | -1.9 | -1.65 |
| 60 Days Ago | -0.39 | -0.38 | -1.9 | -1.65 |
| 90 Days Ago | -0.39 | -0.38 | -1.9 | -1.65 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | -- | 1 | 1 |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QNRX | -- | 61.94% | -- | 19.51% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Maxim Group: Buy to Buy | 3/15/2024 |
Related Tickers
ENSC Ensysce Biosciences, Inc.
8.10
+1.89%
VRAX Virax Biolabs Group Limited
1.7500
-7.41%
TCBP TC Biopharm (Holdings) Plc
0.6600
+0.15%
PHIO Phio Pharmaceuticals Corp.
1.7600
+1.15%
ABP Abpro Holdings, Inc.
2.0700
+38.93%
OGEN Oragenics, Inc.
0.3552
-5.53%
SLXN Silexion Therapeutics Corp
2.4400
+0.83%
PBM Psyence Biomedical Ltd.
3.1800
+29.27%
SPRC SciSparc Ltd.
0.2133
-0.19%
CDIO Cardio Diagnostics Holdings, Inc.
0.9738
-4.53%